vs

Side-by-side financial comparison of DESCARTES SYSTEMS GROUP INC (DSGX) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $179.8M, roughly 1.1× DESCARTES SYSTEMS GROUP INC). DESCARTES SYSTEMS GROUP INC runs the higher net margin — 21.1% vs 6.7%, a 14.4% gap on every dollar of revenue. DESCARTES SYSTEMS GROUP INC produced more free cash flow last quarter ($62.1M vs $17.6M).

The Descartes Systems Group Inc. is a Canadian multinational technology company specializing in logistics software, supply chain management software, and cloud-based services for logistics businesses.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

DSGX vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.1× larger
RGEN
$197.9M
$179.8M
DSGX
Higher net margin
DSGX
DSGX
14.4% more per $
DSGX
21.1%
6.7%
RGEN
More free cash flow
DSGX
DSGX
$44.5M more FCF
DSGX
$62.1M
$17.6M
RGEN

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
DSGX
DSGX
RGEN
RGEN
Revenue
$179.8M
$197.9M
Net Profit
$38.0M
$13.3M
Gross Margin
76.9%
52.5%
Operating Margin
26.8%
9.0%
Net Margin
21.1%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.43
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DSGX
DSGX
RGEN
RGEN
Q4 25
$197.9M
Q3 25
$179.8M
$188.8M
Q2 25
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$163.4M
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
DSGX
DSGX
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$38.0M
$14.9M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$34.7M
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
DSGX
DSGX
RGEN
RGEN
Q4 25
52.5%
Q3 25
76.9%
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
75.2%
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
DSGX
DSGX
RGEN
RGEN
Q4 25
9.0%
Q3 25
26.8%
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
28.1%
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
DSGX
DSGX
RGEN
RGEN
Q4 25
6.7%
Q3 25
21.1%
7.9%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
21.2%
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
DSGX
DSGX
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.43
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$0.40
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DSGX
DSGX
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$240.6M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.5B
$2.1B
Total Assets
$1.8B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DSGX
DSGX
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$240.6M
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$252.7M
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
DSGX
DSGX
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DSGX
DSGX
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$1.5B
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$1.3B
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
DSGX
DSGX
RGEN
RGEN
Q4 25
$2.9B
Q3 25
$1.8B
$2.9B
Q2 25
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$1.6B
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
DSGX
DSGX
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DSGX
DSGX
RGEN
RGEN
Operating Cash FlowLast quarter
$63.3M
$25.7M
Free Cash FlowOCF − Capex
$62.1M
$17.6M
FCF MarginFCF / Revenue
34.5%
8.9%
Capex IntensityCapex / Revenue
0.7%
4.1%
Cash ConversionOCF / Net Profit
1.67×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$189.6M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DSGX
DSGX
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$63.3M
$48.1M
Q2 25
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$34.7M
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
DSGX
DSGX
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$62.1M
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$33.1M
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
DSGX
DSGX
RGEN
RGEN
Q4 25
8.9%
Q3 25
34.5%
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
20.2%
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
DSGX
DSGX
RGEN
RGEN
Q4 25
4.1%
Q3 25
0.7%
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
1.0%
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
DSGX
DSGX
RGEN
RGEN
Q4 25
1.93×
Q3 25
1.67×
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
1.00×
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons